Loading company details…
Dysruptx Ltd develops precision macro‑cyclic peptide therapeutics, branded as “Dysruptors,” engineer Sign up to read more
No share issues or funding rounds.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| CONNOR WILLIAM BLAIR | ORDINARY | 100 | 59.9% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
2 more shareholders on file , sign up free to see.
Companies with the most similar business descriptions.
These are the directors and secretaries who have left DYSRUPTX LTD. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.